+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Global Clinical Trials Site Management Organizations Market by Phase (Phase I, Phase II, Phase III), Services (Onsite Monitoring, Project Management, Regulatory Compliance), Therapeutic Areas - Forecast 2024-2030

  • PDF Icon

    Report

  • 183 Pages
  • March 2024
  • Region: Global
  • 360iResearch™
  • ID: 5612943
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Clinical Trials Site Management Organizations Market size was estimated at USD 7.38 billion in 2023, USD 8.00 billion in 2024, and is expected to grow at a CAGR of 8.65% to reach USD 13.21 billion by 2030.

Clinical trial site management organizations are responsible for recruiting patients, coordinating training and meetings for staff, managing study budgets, and more during various phases of clinical trials. They also help ensure that sites are compliant with relevant regulations, as well as make sure that all participants in the trial are receiving quality care. The utilization of site management organizations has surged considerably in recent years, with the prevalence of communicable and non-communicable diseases encouraging drug development activities. Moreover, investments made by government agencies and pharmaceutical and biopharmaceutical manufacturers and the need for cost-effective management of clinical trial activities also encourage the use of site management organizations. On the other hand, issues pertaining to managing and coordinating different clinical trial research sites and shortages of trained staff hinder their utilization. However, the adoption of innovative technologies in clinical trial management and monitoring, coupled with a continuous increase in the number of research sites across the globe, is expected to support the adoption of clinical trial site management services in the coming years.

Regional Insights

The utilization of clinical trial site management organizations is surging in the United States, China, Japan, India, Germany, United Kingdom, France, Iran, and Canada, among others, with a higher number of clinical trials and a strong presence of healthcare, pharmaceutical, and biotechnology sectors. In order to ensure successful outcomes, clinical trial site management organizations develop strong partnerships with healthcare providers, research teams, sponsors, and other stakeholders. Moreover, regulatory organizations such as the United States Food and Drug Administration (FDA), the National Health Surveillance Agency (Agência Nacional de Vigilância Sanitária (ANVISA), Health Canada, Therapeutic Goods Administration (TGA), and many others establishing regulatory frameworks for drug development, there is considerable scope for the utilization of site management services. In developing countries such as Mexico, Brazil, Thailand, and countries such as Norway, Sweden, and Denmark, the governments are making considerable investments to encourage research and technological advancements to boost the development of medical & healthcare infrastructure, ensuring economic growth of the nations and public welfare. Electronic medical record (EMR) systems and the use of cloud-based technologies to improve communication between sites allow teams to collaborate more effectively on larger scale projects is expected to proliferate the use of clinical trial site management organizations in the coming years.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Clinical Trials Site Management Organizations Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Clinical Trials Site Management Organizations Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Clinical Trials Site Management Organizations Market, highlighting leading vendors and their innovative profiles. These include Accel Clinical Services, Accelagen, Access Clinical Research, Altasciences, Canvass Clinical Research Services Pvt. Ltd., Celerion, ClinChoice, Clinical Development Solutions, CMIC HOLDINGS Co., LTD., Criterium, Inc., FIDELIS RESEARCH AD, FOMAT Medical Research Inc., George Clinical Pty Ltd,, Grand Pacific CRO, ICON PLC, IQVIA Inc., KV Clinical Research Services, L.E.K. Consulting LLC, MCRA, LLC, Medigence Solutions Pvt Ltd., Novotech, Parexel International Corporation, PPD Inc. by Thermo Fisher Scientific Inc., PROMETRIKA, LLC., ProTrials Research, Inc., Red Maple Trials Inc., SGS S.A., Veristat, LLC., Vial Health Technology, Inc., WIRB-Copernicus Group, Worldwide Clinical Trials, Xylem Clinical Research Pvt. Ltd., and Zave Clinical Research Management.

Market Segmentation & Coverage

This research report categorizes the Clinical Trials Site Management Organizations Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Phase
    • Phase I
    • Phase II
    • Phase III
    • Phase IV
  • Services
    • Onsite Monitoring
    • Project Management
    • Regulatory Compliance
    • Site Management
  • Therapeutic Areas
    • Cardiology
    • Central Nervous System
    • Endocrine
    • Oncology
    • Pain Management
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as

  1. What is the market size and forecast of the Clinical Trials Site Management Organizations Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Clinical Trials Site Management Organizations Market?
  3. What are the technology trends and regulatory frameworks in the Clinical Trials Site Management Organizations Market?
  4. What is the market share of the leading vendors in the Clinical Trials Site Management Organizations Market?
  5. Which modes and strategic moves are suitable for entering the Clinical Trials Site Management Organizations Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Clinical Trials Site Management Organizations Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing risk of health issues and growing number of clinical trials
5.1.1.2. Rising private and public investments in pharmaceutical research across the globe
5.1.1.3. Strong clinical trial regulatory frameworks and need for cost-effective management services
5.1.2. Restraints
5.1.2.1. Complexities associated with multi-site communication and coordination
5.1.3. Opportunities
5.1.3.1. Integration of advanced technologies in clinical trial site management operations
5.1.3.2. Expansion of clinical trial research facilities with improving healthcare infrastructure
5.1.4. Challenges
5.1.4.1. Limited availability of skilled and trained personnel
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Clinical Trials Site Management Organizations Market, by Phase
6.1. Introduction
6.2. Phase I
6.3. Phase II
6.4. Phase III
6.5. Phase IV
7. Clinical Trials Site Management Organizations Market, by Services
7.1. Introduction
7.2. Onsite Monitoring
7.3. Project Management
7.4. Regulatory Compliance
7.5. Site Management
8. Clinical Trials Site Management Organizations Market, by Therapeutic Areas
8.1. Introduction
8.2. Cardiology
8.3. Central Nervous System
8.4. Endocrine
8.5. Oncology
8.6. Pain Management
9. Americas Clinical Trials Site Management Organizations Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Clinical Trials Site Management Organizations Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Clinical Trials Site Management Organizations Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player
12.3.1. Merger & Acquisition
12.3.1.1. Neutra Executes LOI to Acquire Private Clinical Research
12.3.1.2. Latticework Capital Management Forms Site Management Organization Holding Company, Acquires Catalina Research Institute, LLC
12.3.2. Agreement, Collaboration, & Partnership
12.3.2.1. Empower Clinics Expands Partnership to Launch US Clinical Trial Management Services by Forming a Delaware Based Company
12.3.3. Investment & Funding
12.3.3.1. Site management organization Panthera Biosciences raises USD 10 million for expansion
13. Competitive Portfolio
13.1. Key Company Profiles
13.1.1. Accel Clinical Services
13.1.2. Accelagen
13.1.3. Access Clinical Research
13.1.4. Altasciences
13.1.5. Canvass Clinical Research Services Pvt. Ltd.
13.1.6. Celerion
13.1.7. ClinChoice
13.1.8. Clinical Development Solutions
13.1.9. CMIC HOLDINGS Co., LTD.
13.1.10. Criterium, Inc.
13.1.11. FIDELIS RESEARCH AD
13.1.12. FOMAT Medical Research Inc.
13.1.13. George Clinical Pty Ltd,
13.1.14. Grand Pacific CRO
13.1.15. ICON PLC
13.1.16. IQVIA Inc.
13.1.17. KV Clinical Research Services
13.1.18. L.E.K. Consulting LLC
13.1.19. MCRA, LLC
13.1.20. Medigence Solutions Pvt Ltd.
13.1.21. Novotech
13.1.22. Parexel International Corporation
13.1.23. PPD Inc. by Thermo Fisher Scientific Inc.
13.1.24. PROMETRIKA, LLC.
13.1.25. ProTrials Research, Inc.
13.1.26. Red Maple Trials Inc.
13.1.27. SGS S.A.
13.1.28. Veristat, LLC.
13.1.29. Vial Health Technology, Inc.
13.1.30. WIRB-Copernicus Group
13.1.31. Worldwide Clinical Trials
13.1.32. Xylem Clinical Research Pvt. Ltd.
13.1.33. Zave Clinical Research Management
13.2. Key Product Portfolio
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing
List of Figures
FIGURE 1. CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET RESEARCH PROCESS
FIGURE 2. CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, 2023 VS 2030
FIGURE 3. CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET DYNAMICS
FIGURE 7. CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2023 VS 2030 (%)
FIGURE 8. CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2023 VS 2030 (%)
FIGURE 10. CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2023 VS 2030 (%)
FIGURE 12. CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 22. CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SHARE, BY KEY PLAYER, 2023
List of Tables
TABLE 1. CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 6. CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE I, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE II, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE III, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE IV, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 11. CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY ONSITE MONITORING, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PROJECT MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY REGULATORY COMPLIANCE, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SITE MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 16. CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY CENTRAL NERVOUS SYSTEM, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY ENDOCRINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. AMERICAS CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 22. AMERICAS CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 23. AMERICAS CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 24. AMERICAS CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 25. ARGENTINA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 26. ARGENTINA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 27. ARGENTINA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 28. BRAZIL CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 29. BRAZIL CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 30. BRAZIL CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 31. CANADA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 32. CANADA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 33. CANADA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 34. MEXICO CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 35. MEXICO CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 36. MEXICO CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 37. UNITED STATES CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 38. UNITED STATES CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 39. UNITED STATES CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 40. UNITED STATES CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 41. ASIA-PACIFIC CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 42. ASIA-PACIFIC CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 43. ASIA-PACIFIC CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 44. ASIA-PACIFIC CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 45. AUSTRALIA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 46. AUSTRALIA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 47. AUSTRALIA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 48. CHINA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 49. CHINA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 50. CHINA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 51. INDIA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 52. INDIA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 53. INDIA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 54. INDONESIA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 55. INDONESIA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 56. INDONESIA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 57. JAPAN CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 58. JAPAN CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 59. JAPAN CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 60. MALAYSIA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 61. MALAYSIA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 62. MALAYSIA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 63. PHILIPPINES CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 64. PHILIPPINES CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 65. PHILIPPINES CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 66. SINGAPORE CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 67. SINGAPORE CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 68. SINGAPORE CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 69. SOUTH KOREA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 70. SOUTH KOREA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 71. SOUTH KOREA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 72. TAIWAN CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 73. TAIWAN CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 74. TAIWAN CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 75. THAILAND CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 76. THAILAND CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 77. THAILAND CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 78. VIETNAM CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 79. VIETNAM CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 80. VIETNAM CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 81. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 82. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 83. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 84. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 85. DENMARK CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 86. DENMARK CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 87. DENMARK CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 88. EGYPT CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 89. EGYPT CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 90. EGYPT CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 91. FINLAND CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 92. FINLAND CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 93. FINLAND CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 94. FRANCE CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 95. FRANCE CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 96. FRANCE CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 97. GERMANY CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 98. GERMANY CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 99. GERMANY CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 100. ISRAEL CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 101. ISRAEL CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 102. ISRAEL CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 103. ITALY CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 104. ITALY CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 105. ITALY CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 106. NETHERLANDS CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 107. NETHERLANDS CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 108. NETHERLANDS CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 109. NIGERIA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 110. NIGERIA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 111. NIGERIA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 112. NORWAY CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 113. NORWAY CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 114. NORWAY CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 115. POLAND CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 116. POLAND CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 117. POLAND CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 118. QATAR CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 119. QATAR CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 120. QATAR CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 121. RUSSIA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 122. RUSSIA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 123. RUSSIA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 124. SAUDI ARABIA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 125. SAUDI ARABIA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 126. SAUDI ARABIA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 127. SOUTH AFRICA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 128. SOUTH AFRICA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 129. SOUTH AFRICA CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 130. SPAIN CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 131. SPAIN CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 132. SPAIN CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 133. SWEDEN CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 134. SWEDEN CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 135. SWEDEN CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 136. SWITZERLAND CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 137. SWITZERLAND CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 138. SWITZERLAND CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 139. TURKEY CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 140. TURKEY CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 141. TURKEY CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 142. UNITED ARAB EMIRATES CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 143. UNITED ARAB EMIRATES CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 144. UNITED ARAB EMIRATES CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 145. UNITED KINGDOM CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 146. UNITED KINGDOM CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 147. UNITED KINGDOM CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 148. CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 149. CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET SHARE, BY KEY PLAYER, 2023
TABLE 150. CLINICAL TRIALS SITE MANAGEMENT ORGANIZATIONS MARKET LICENSE & PRICING

Companies Mentioned

  • Accel Clinical Services
  • Accelagen
  • Access Clinical Research
  • Altasciences
  • Canvass Clinical Research Services Pvt. Ltd.
  • Celerion
  • ClinChoice
  • Clinical Development Solutions
  • CMIC HOLDINGS Co., LTD.
  • Criterium, Inc.
  • FIDELIS RESEARCH AD
  • FOMAT Medical Research Inc.
  • George Clinical Pty Ltd,
  • Grand Pacific CRO
  • ICON PLC
  • IQVIA Inc.
  • KV Clinical Research Services
  • L.E.K. Consulting LLC
  • MCRA, LLC
  • Medigence Solutions Pvt Ltd.
  • Novotech
  • Parexel International Corporation
  • PPD Inc. by Thermo Fisher Scientific Inc.
  • PROMETRIKA, LLC.
  • ProTrials Research, Inc.
  • Red Maple Trials Inc.
  • SGS S.A.
  • Veristat, LLC.
  • Vial Health Technology, Inc.
  • WIRB-Copernicus Group
  • Worldwide Clinical Trials
  • Xylem Clinical Research Pvt. Ltd.
  • Zave Clinical Research Management

Methodology

Loading
LOADING...

Table Information